litlas
Log inCreate account

Giovanni Martinelli

Active 1986–2025

362
Papers
44,913
Citations
113
h-index
332
i10-index

Citations

Citations per year for Giovanni Martinelli1979: 10 citations1991: 3 citations1993: 1 citations1994: 2 citations1995: 1 citations1996: 4 citations1997: 7 citations1998: 4 citations1999: 14 citations2000: 37 citations2001: 39 citations2002: 58 citations2003: 113 citations2004: 143 citations2005: 142 citations2006: 174 citations2007: 179 citations2008: 219 citations2009: 270 citations2010: 267 citations2011: 272 citations2012: 294 citations2013: 347 citations2014: 276 citations2015: 328 citations2016: 350 citations2017: 353 citations2018: 320 citations2019: 1,283 citations2020: 1,463 citations2021: 1,518 citations2022: 1,282 citations2023: 878 citations2024: 1,480 citations2025: 671 citations2026: 9 citations1980–1990: no citations, so these years are not shown1992: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,992 citing papers, 24.1% of this breakdownItaly: 1,479 citing papers, 8.9% of this breakdownChina: 1,298 citing papers, 7.9% of this breakdownGermany: 1,158 citing papers, 7% of this breakdownUnited Kingdom: 932 citing papers, 5.6% of this breakdownFrance: 831 citing papers, 5% of this breakdownSpain: 520 citing papers, 3.2% of this breakdownCanada: 472 citing papers, 2.9% of this breakdownSwitzerland: 451 citing papers, 2.7% of this breakdownNetherlands: 435 citing papers, 2.6% of this breakdownAustralia: 420 citing papers, 2.5% of this breakdownJapan: 381 citing papers, 2.3% of this breakdown
0%24.1%Other 25.3%

Institutions

Fields

  • Medicine68.2%
  • Biochemistry, Genetics and Molecular Biology18.2%
  • Immunology and Microbiology6%
  • Engineering1.8%
  • Earth and Planetary Sciences1.3%
  • Computer Science1.3%
  • Other3.2%

Topics

  • Acute Myeloid Leukemia Research7.4%
  • Chronic Myeloid Leukemia Treatments6.1%
  • Acute Lymphoblastic Leukemia research4.1%
  • CAR-T cell therapy research3.6%
  • Chronic Lymphocytic Leukemia Research3.5%
  • Lymphoma Diagnosis and Treatment3%
  • Other72.3%

Coauthors

All papers

Open in search
  1. Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3 -Mutated AML

    Authors: Alexander E. Perl, Giovanni Martinelli, Jörge E. Cortes, Andreas Neubauer, Ellin Berman, Stefania Paolini, Pau Montesinos, Maria R. Baer, Richard A. Larson, Celalettin Üstün, Francesco Fabbiano, Harry P. Erba, Antonio Di Stasi, Robert K. Stuart, Rebecca L. Olin, Margaret Kasner, Fabio Ciceri, Wen‐Chien Chou, Nikolai A. Podoltsev, Christian Récher, Hisayuki Yokoyama, Naoko Hosono, Sung‐Soo Yoon, Je‐Hwan Lee, Timothy S. Pardee, Amir T. Fathi, Chaofeng Liu, Nahla Hasabou, Xuan Liu, Erkut Bahceci, Mark J. Levis - New England Journal of Medicine 2019 cited by 1,239

  2. Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia

    Authors: Hagop M. Kantarjian, Daniel J. DeAngelo, Matthias Stelljes, Giovanni Martinelli, Michaela Liedtke, Wendy Stock, Nicola Gökbuget, Susan O’Brien, Kongming Wang, Tao Wang, M. Luisa Paccagnella, Barbara Sleight, Erik Vandendries, Anjali S. Advani - New England Journal of Medicine 2016 cited by 1,373

  3. MDM2 inhibition: an important step forward in cancer therapy

    Authors: Marina Konopleva, Giovanni Martinelli, Naval Daver, Cristina Papayannidis, Andrew H. Wei, Brian Higgins, Marion Ott, John Mascarenhas, Michael Andreeff - Leukemia 2020 cited by 384

  4. A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target

    Authors: Andrea Ghelli Luserna di Rorà, Claudio Cerchione, Giovanni Martinelli, Giorgia Simonetti - Journal of Hematology & Oncology 2020 cited by 314

  5. International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

    Authors: Hervé Dombret, John F. Seymour, Aleksandra Butrym, Agnieszka Wierzbowska, Dominik Selleslag, Jun Ho Jang, Rajat Kumar, James D. Cavenagh, Andre C. Schuh, Anna Candoni, Christian Récher, Irwindeep Sandhu, Teresa Bernal del Castillo, Haifa Kathrin Al‐Ali, Giovanni Martinelli, José Falantes, Richard Noppeney, Richard M. Stone, Mark D. Minden, Heidi McIntyre, S. Songer, Lela M. Lucy, C. L. Beach, Hartmut Döhner - Blood 2015 cited by 1,149

  6. Colour deconvolution: stain unmixing in histological imaging

    Authors: Gabriel Landini, Giovanni Martinelli, Filippo Piccinini - Bioinformatics, Bioinform. 2020 cited by 246

  7. Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial

    Authors: Jörge E. Cortes, Samer K. Khaled, Giovanni Martinelli, Alexander E. Perl, Siddhartha Ganguly, Nigel H. Russell, Alwin Krämer, Hervé Dombret, Donna E. Hogge, Brian A. Jonas, Anskar Y.H. Leung, Priyanka Mehta, Pau Montesinos, Markus P. Radsak, Simona Sica, Meena Arunachalam, Melissa F. Holmes, Ken Kobayashi, Ruth Namuyinga, Nanxiang Ge, Antoine Yver, Yufen Zhang, Mark J. Levis - The Lancet Oncology 2019 cited by 479

  8. Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia

    Authors: Michael Andreeff, Kevin R. Kelly, Karen Yee, Sarit Assouline, Roger Strair, Leslie Popplewell, David Bowen, Giovanni Martinelli, Mark W. Drummond, Paresh Vyas, Mark Kirschbaum, Swaminathan P. Iyer, Vivian Ruvolo, Graciela M. Nogueras‐González, Xuelin Huang, Gong Chen, Bradford Graves, Steven Blotner, Peter J. Bridge, Lori Jukofsky, Steve Middleton, Monica Reckner, Ruediger Rueger, Jianguo Zhi, Gwen Nichols, Kensuke Kojima - Clinical Cancer Research 2015 cited by 353

  9. Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial

    Authors: Naval Daver, Monique Dail, Jacqueline S. Garcia, Brian A. Jonas, Karen Yee, Kevin R. Kelly, Norbert Vey, Sarit Assouline, Gail J. Roboz, Stefania Paolini, Daniel A. Pollyea, Agostino Tafuri, Joseph Brandwein, Arnaud Pigneux, Bayard L. Powell, Pierre Fenaux, Rebecca L. Olin, Giuseppe Visani, Giovanni Martinelli, Maika Onishi, Jue Wang, Weize Huang, Cherie Green, Marion Ott, Wan‐Jen Hong, Marina Konopleva, Michael Andreeff - Blood 2022 cited by 102

  10. Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition

    Authors: Daniela Cardinale, Alessandro Colombo, Maria Teresa Sandri, Giuseppina Lamantia, N. Colombo, Maurizio Civelli, Giovanni Martinelli, Fabrizio Veglia, Cesare Fiorentini, Carlo M. Cipolla - Circulation 2006 cited by 1,021

  11. Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1–2 study

    Authors: Alexander E. Perl, Jessica K. Altman, Jörge E. Cortes, Catherine C. Smith, Mark R. Litzow, Maria R. Baer, David F. Claxton, Harry P. Erba, Stan Gill, Stuart L. Goldberg, Joseph G. Jurcic, Richard A Larson, Chaofeng Liu, Ellen K. Ritchie, Gary J. Schiller, Alexander I. Spira, Stephen A. Strickland, Raoul Tibes, Celalettin Üstün, Eunice S. Wang, Robert K. Stuart, Christoph Röllig, Andreas Neubauer, Giovanni Martinelli, Erkut Bahceci, Mark J. Levis - The Lancet Oncology 2017 cited by 488

  12. A large-scale database of T-cell receptor beta (TCRβ) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.

    Authors: Sean Nolan, Marissa Vignali, Mark Klinger, Jennifer N. Dines, Ian M. Kaplan, Emily Svejnoha, Tracy Craft, Katie Boland, Mitch Pesesky, Rachel Gittelman, Thomas M. Snyder, Christopher J. Gooley, Simona Semprini, Claudio Cerchione, Massimiliano Mazza, Ottavia M. Delmonte, Kerry Dobbs, Gonzalo Carreño‐Tarragona, Santiago Barrio, Vittorio Sambri, Giovanni Martinelli, Jason D. Goldman, James R. Heath, Luigi D. Notarangelo, Jonathan M. Carlson, Joaquín Martínez‐López, Harlan Robins - 2020 cited by 166

  13. Follow-up of patients with R/R FLT3-mutation–positive AML treated with gilteritinib in the phase 3 ADMIRAL trial

    Authors: Alexander E. Perl, Richard A. Larson, Nikolai A. Podoltsev, Stephen A. Strickland, Eunice S. Wang, Ehab Atallah, Gary J. Schiller, Giovanni Martinelli, Andreas Neubauer, Jorge Sierra, Pau Montesinos, Christian Récher, Sung‐Soo Yoon, Naoko Hosono, Masahiro Onozawa, Shigeru Chiba, Hee‐Je Kim, Nahla Hasabou, Qiaoyang Lu, Ramón V. Tiu, Mark J. Levis - Blood 2022 cited by 137

  14. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

    Authors: Michele Baccarani, Michael Deininger, Gianantonio Rosti, Andreas Hochhaus, Simona Soverini, Jane F. Apperley, Francisco Cervantes, Richard E. Clark, Jörge E. Cortes, François Guilhot, Henrik Hjorth‐Hansen, Timothy P. Hughes, Hagop M. Kantarjian, Dong‐Wook Kim, Richard A. Larson, Jeffrey H. Lipton, François-Xavier Mahon, Giovanni Martinelli, Jiřı́ Mayer, Martin Müller, Dietger Niederwieser, Fabrizio Pane, Jerald P. Radich, Philippe Rousselot, Giuseppe Saglio, Susanne Saußele, Charles A. Schiffer, Richard T. Silver, Bengt Simonsson, Juan-Luis Steegmann, John M. Goldman, Rüdiger Hehlmann - Blood 2013 cited by 1,989

  15. Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

    Authors: Massimo Federico, Monica Bellei, Luigi Marcheselli, Stefano Luminari, Armando López‐Guillermo, Umberto Vitolo, Barbara Pro, Stefano Pileri, Alessandro Pulsoni, Pierre Soubeyran, Sergio Cortelazzo, Giovanni Martinelli, Maurizio Martelli, Luigi Rigacci, Luca Arcaini, Francesco Di Raimondo, Francesco Merli, Elena Sabattini, Peter McLaughlin, Philippe Solal‐Céligny - Journal of Clinical Oncology 2009 cited by 751

  16. Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome–Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study

    Authors: Giovanni Martinelli, Nicolas Boissel, Patrice Chevallier, Oliver G. Ottmann, Nicola Gökbuget, Max S. Topp, Adele K. Fielding, Alessandro Rambaldi, Ellen K. Ritchie, Cristina Papayannidis, Lulu Ren Sterling, Jonathan Benjamin, Anthony S. Stein - Journal of Clinical Oncology 2017 cited by 446

  17. GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

    Authors: Adriano Venditti, Alfonso Piciocchi, Anna Candoni, Lorella Melillo, Valeria Calafiore, Roberto Cairoli, Paolo de Fabritiis, Gabriella Storti, Prassede Salutari, Francesco Lanza, Giovanni Martinelli, Mario Luppi, Patrizio Mazza, Maria Paola Martelli, Antonio Cuneo, Francesco Albano, Francesco Fabbiano, Agostino Tafuri, Anna Chierichini, Alessia Tieghi, Nicola Fracchiolla, Debora Capelli, Robin Foà, Caterina Alati, Edoardo La Sala, Paola Fazi, Marco Vignetti, Luca Maurillo, Francesco Buccisano, Maria Ilaria Del Principe, Maria Antonietta Irno-Consalvo, Tiziana Ottone, Serena Lavorgna, Maria Teresa Voso, Francesco Lo‐Coco, William Arcese, Sergio Amadori - Blood 2019 cited by 215

  18. Prognostic Value of Troponin I in Cardiac Risk Stratification of Cancer Patients Undergoing High-Dose Chemotherapy

    Authors: Daniela Cardinale, Maria Teresa Sandri, Alessandro Colombo, N. Colombo, Marina Boeri, Giuseppina Lamantia, Maurizio Civelli, Fedro A. Peccatori, Giovanni Martinelli, Cesare Fiorentini, Carlo M. Cipolla - Circulation 2004 cited by 943

  19. Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

    Authors: Robin Foà, Antonella Vitale, Marco Vignetti, Giovanna Meloni, Anna Guarini, Maria Stefania De Propris, Loredana Elia, Francesca Paoloni, Paola Fazi, Giuseppe Cimino, Francesco Nobile, Felicetto Ferrara, Carlo Castagnola, Simona Sica, Pietro Leoni, Eliana Zuffa, Claudio Fozza, Mario Luppi, Anna Candoni, Ilaria Iacobucci, Simona Soverini, Franco Mandelli, Giovanni Martinelli, Michele Baccarani, on behalf of the GIMEMA Acute Leukemia Working Party - Blood 2011 cited by 461

  20. Idasanutlin Plus Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia: Results of the MIRROS Trial

    Authors: Marina Konopleva, Christoph Röllig, Jamie Cavenagh, Dries Deeren, Larisa Girshova, Jürgen Krauter, Giovanni Martinelli, Pau Montesinos, Jonas Schäfer, Oliver G. Ottmann, Mario Petrini, Arnaud Pigneux, Alessandro Rambaldi, Christian Récher, Rebeca Rodríguez‐Veiga, David Taussig, Norbert Vey, Sung‐Soo Yoon, Marion Ott, Susanne Muehlbauer, Benjamin M. Beckermann, Olivier Catalani, Magali Genevray, Kirsten Mundt, Candice Jamois, Pierre Fenaux, Andrew H. Wei - Blood Advances 2022 cited by 70

  21. Migration of carrier and trace gases in the geosphere: an overview

    Authors: Giuseppe Etiope, Giovanni Martinelli - Physics of The Earth and Planetary Interiors 2002 cited by 433

  22. Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy

    Authors: Simona Soverini, Manuela Mancini, Luana Bavaro, Michèle Cavo, Giovanni Martinelli - Molecular Cancer 2018 cited by 229

  23. The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer

    Authors: Giuseppe Schepisi, Caterina Gianni, Michela Palleschi, Sara Bleve, Chiara Casadei, Cristian Lolli, Laura Ridolfi, Giovanni Martinelli, Ugo De Giorgi - Cancers 2023 cited by 39

  24. Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients

    Authors: Antonio Curti, Loredana Ruggeri, Alessandra D’Addio, Andrea Bontadini, Elisa Dan, Maria Rosa Motta, Sara Trabanelli, Valeria Giudice, Elena Urbani, Giovanni Martinelli, Stefania Paolini, Fiorenza Fruet, Alessandro Isidori, Sarah Parisi, Giuseppe Bandini, Michele Baccarani, Andrea Velardi, Roberto M. Lemoli - Blood 2011 cited by 402